Literature DB >> 15272295

Ocular motility findings in chronic progressive external ophthalmoplegia.

C Richardson1, T Smith, A Schaefer, D Turnbull, P Griffiths.   

Abstract

AIMS: To characterise the ocular motility features of chronic progressive external opthalmoplegia by quantitative and semiquantitative means. To assess the prevalence of diplopia and the binocular adaptations to nonaligned visual axes.
METHOD: We studied 25 patients with chronic progressive external ophthalmoplegia. In each case muscle biopsies were consistent with mitochondrial myopathy. All patients underwent cover test in the primary position, assessment of binocular status, and measurement of uniocular fields of fixation using the Goldmann perimeter.
RESULTS: A total of 23 (92%) patients had an exo-deviation, with six (26%) of those having an associated vertical deviation: 12 patients were binocular. Of the 13 patients with a manifest deviation seven had diplopia and six had suppression. Of all paired extra-ocular muscles (EOM), 68% had symmetry of movement within 5 degrees of each other.
CONCLUSION: Almost all patients had an exo-deviation. Diplopia was more common than expected. The majority of patients had symmetry of EOM limitation.

Entities:  

Mesh:

Year:  2005        PMID: 15272295     DOI: 10.1038/sj.eye.6701488

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  14 in total

1.  Some physicochemical properties of hemoglobin-manitoba (alpha2 102Ser replaced by Arg (G9) beta2).

Authors:  R N Wrightstone; L L Smith; J B Wilson; F Vella; T H Huisman
Journal:  Biochim Biophys Acta       Date:  1975-12-15

2.  Hemifacial presentation of mitochondrial myopathy.

Authors:  Nadeem Ali; James Acheson
Journal:  J Neurol       Date:  2011-01-26       Impact factor: 4.849

3.  Simultaneous, Bilateral Ophthalmoplegia as the Presenting Sign of Paediatric Multiple Sclerosis: Case Report and Discussion of the Differential Diagnosis.

Authors:  Murtaza K Adam; Kelly Krespan; Mark L Moster; Robert C Sergott
Journal:  Neuroophthalmology       Date:  2014-06-09

Review 4.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

5.  A reinterpretation of certain disorders affecting the eye muscles and their tissues.

Authors:  Anuchit Poonyathalang; Sangeeta Khanna; R John Leigh
Journal:  Clin Ophthalmol       Date:  2007-12

6.  [Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome : interdisciplinary diagnosis and therapy].

Authors:  B Wabbels; N Ali; W S Kunz; P Roggenkämper; C Kornblum
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

7.  Electron microscopic findings in levator muscle biopsies of patients with isolated congenital or acquired ptosis.

Authors:  Bettina Wabbels; Josef A Schroeder; Beate Voll; Heiko Siegmund; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-24       Impact factor: 3.117

Review 8.  Progressive External Ophthalmoplegia.

Authors:  Collin McClelland; Georgios Manousakis; Michael S Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

9.  Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO.

Authors:  Laura C Greaves; Patrick Yu-Wai-Man; Emma L Blakely; Kim J Krishnan; Nina E Beadle; Jamie Kerin; Martin J Barron; Philip G Griffiths; Alison J Dickinson; Douglass M Turnbull; Robert W Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

10.  International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy.

Authors:  Michelangelo Mancuso; Robert McFarland; Thomas Klopstock; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2017-09-08       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.